SpaceX is reportedly preparing for a record-breaking IPO that could value the company at nearly $1.75 trillion and raise around $75 billion. Investor enthusiasm is being driven by the company’s dominance in rockets, satellite internet, and AI-linked technologies, though concerns around valuation, governance, and execution risks continue to persist.
Indian government bonds declined early Wednesday as rising U.S. Treasury yields diminished the appeal of emerging-market debt, leading to outflows and weakening the rupee. The benchmark 2035 bond yield increased, while the yield premium on Indian bonds narrowed. Higher global yields and geopolitical uncertainty also contributed to market pressures.
Indian markets show signs of life, but expert Nischal Maheshwari urges caution. He sees a dead cat bounce in IT stocks and advises against chasing short-term gains. Green energy and export stocks are highlighted as long-term opportunities. Ferrous metals and defence sectors also present attractive prospects. Investors should be selective and focus on real earnings support.
Promoters reduced their holdings in 18 smallcap companies during the January to March quarter. Bandhan Bank, Urban Company, and Aadhar Housing Finance are among those where promoter stakes fell. This trend was identified in a report by JM Financial. Investors are watching these movements closely.
Global bond yields are climbing, prompting investors to re-evaluate market risks. This rise pressures equities, particularly those in the artificial intelligence sector. Experts note markets are reacting to inflation worries and oil price impacts. Investors are also adjusting to new leadership at the US Federal Reserve. This shift suggests a broadening of equity exposure beyond narrow AI plays.
Nvidia’s earnings face intense scrutiny as investors demand not only another massive AI-driven beat, but stronger guidance, Blackwell momentum, resilient margins, and proof long-term growth can justify soaring valuations amid rising competition.
GE Vernova T&D India shares jumped after the company posted a strong Q4FY26 performance. Net profit surged 89% year-on-year to Rs 352 crore, while revenue rose 42% to Rs 1,640 crore. EBITDA also climbed 77% to Rs 440 crore, supported by robust operational growth and strong order inflows.
Vodafone Idea shares have surged over 100% in a year. Analysts from Macquarie, JPMorgan, and other global brokerages offer mixed views. While some see potential catalysts like government support and promoter infusion, many highlight significant challenges. Key concerns include securing crucial bank funding for capex and regaining market share. Investors await further developments on debt raising and operational recovery.
Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pharma index rebounded from early losses to rise nearly 1%, crossing the 25,000 mark and hitting a fresh 52-week high of 25,043.
Global markets are under pressure due to rising bond yields and geopolitical tensions. Higher crude oil prices are a key concern, potentially impacting sector margins. Investors are shifting towards defensive sectors like pharma and hospitals. Indian IT firms are seen as value picks, but growth concerns persist. Asset management companies offer a way to play a market recovery.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.